PATENT CLAIM ANALYSIS

Application Number: 16148749
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-04
Patent Classification: ["514", "001000"]

Abstract:
The present disclosure provides methods of treating fibrosis or a fibrotic disease or condition in a subject in need thereof comprising administering to the subject a therapeutically effective amount of cenicriviroc or a salt or solvent thereof. The fibrosis or fibrotic disease may be liver fibrosis, renal fibrosis, non-cirrhotic hepatic fibrosis, associated with non-alcoholic steatohepatitis (NASH), non-alcoholic fatty liver disease (NAFLD), or emerging cirrhosis.

Claim (Index 14):
The method of  claim 1 , wherein the cenicriviroc or salt or solvate thereof is administered once per day or twice per day.

Metadata:
- Claim Count in Document: 37.0
- Percentile: 97.0
- Lexical Diversity: 1.63043
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15612124', '15979881', '15460917', '16133322', '16006615']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6967741988880816
- 35 USC 102 Novelty (BERT): 0.5361125392896405
- Combined Prediction Score: 0.6807080329282374
- Mean Citation Score: 275.954396
- Max Citation Score: 321.28372
- Similarity Product: 181.68870800108908

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test